Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stribild vs ATV/r + Truvada in Treatment-Naive HIV-1
NCT01106586Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Apr 2010; status: completed.
02
Drugs
emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01106586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106586.